Helvetia Group:企業の戦略・SWOT・財務情報

◆英語タイトル:Helvetia Group - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C6194
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Helvetia Group – Strategy, SWOT and Corporate Finance Report
Summary

Helvetia Group – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Helvetia Group (Helvetia) is a multi-line insurance provider. The group offers a wide range of life and non-life insurance and reinsurance products. It offers traditional individual life insurance, group insurance, investment-linked life insurance, and individual life insurance. It also offers insurance products for property, motor vehicle, liability, accident and health, travel, transport, art, and engineering. It also offers customized specialty lines coverage and reinsurance products. The group’s products and services are distributed through its own sales force, direct sales, insurance brokers, partners and agents. It serves retail customers, small and medium-sized businesses and corporates. The group operates through branch offices and subsidiaries in Switzerland, Germany, Austria, Spain, Italy and France. Helvetia is headquartered in St Gallen, Switzerland.

The group reported gross premiums written of CHF8,478.1 million for the fiscal year ended December 2017 (FY2017), which indicates an increase of 0.9% over that in FY2016. Its net premiums written were CHF8,102.6 million in FY2017, which shows an increase of 0.2% over that in FY2016.

Scope

- Detailed information on Helvetia Group required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Helvetia Group in the form of a SWOT analysis
- An in-depth view of the business model of Helvetia Group including a breakdown and examination of key business segments
- Intelligence on Helvetia Group’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Helvetia Group, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Helvetia Group and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Helvetia Group as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Helvetia Group’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 4
Helvetia Group: Company Overview 7
Helvetia Group: Overview and Key Facts 7
Helvetia Group: Overview 7
Helvetia Group: Key Facts 7
Helvetia Group: Locations and Subsidiaries 8
Helvetia Group: Corporate Financial Deals Activity 9
Helvetia Group: Financial Deals Overview 9
Helvetia Group: Targets and Partners 11
Helvetia Group: Top Deals 2014 – 2018YTD* 12
Helvetia Group: Advisors 13
Helvetia Group: Top Legal Advisors 13
Helvetia Group: Mergers and Acquisitions 14
Helvetia Group: Corporate Venturing 15
Helvetia Group: Recent Developments 16
Helvetia Group: News and Events Summary 16
Helvetia Group: Corporate Governance 16
Helvetia Group: Financial Deals 17
Helvetia Group: Financial Performance 17
Appendix 19
Contact Us 19
Methodology 19
About MarketLine 20

List of Tables
Table 1: Helvetia Group: Key Facts
Table 2: Helvetia Group: Locations and Subsidiaries
Table 3: Helvetia Group: Deal Activity by Deal Type - Volume (TTM*)
Table 4: Helvetia Group: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 5: Helvetia Group: M&A Average Deal Size - Value (US$m)
Table 6: Helvetia Group: Targets and Partners
Table 7: Helvetia Group: Top Deals 2014 - 2018YTD*
Table 8: Helvetia Group: Legal Advisor Ranking by Value (US$m)
Table 9: Helvetia Group: M&A Volume and Value Trend (2014 - YTD*2018)
Table 10: Helvetia Group: M&A Activity by Geography (2014 - YTD*2018)
Table 11: Helvetia Group: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 12: Helvetia Group: Corporate Venturing by Geography (2014 - YTD*2018)
Table 13: Helvetia Group: News and Events Summary
Table 14: Helvetia Group: Corporate Governance
Table 15: Helvetia Group: Financial Deals
Table 16: Helvetia Group: Financial Performance

List of Figures
Figure 1: Helvetia Group: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Helvetia Group: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 3: Helvetia Group: M&A Average Deal Size - Value (US$m)
Figure 4: Helvetia Group: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 5: Helvetia Group: M&A Activity by Geography (2014 - YTD*2018)
Figure 6: Helvetia Group: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 7: Helvetia Group: Corporate Venturing by Geography (2014 - YTD*2018)

★海外企業調査レポート[Helvetia Group:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Elite Surgical Supplies (Pty) Ltd:製品パイプライン分析
    Summary Elite Surgical Supplies (Pty) Ltd (Elite Surgical) is a medical device company that manufactures and distributes surgical instruments. The company provides spinal, arthoplasty and consumable surgical instruments. Its spinal products include stand alone equipment, cervical cage, boiling VBR, …
  • Telstra Corporation Limited:企業の戦略・SWOT・財務情報
    Telstra Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary Telstra Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Tadano Ltd:企業の戦略・SWOT・財務情報
    Tadano Ltd - Strategy, SWOT and Corporate Finance Report Summary Tadano Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Reichhold LLC 2:企業の戦略的SWOT分析
    Reichhold LLC 2 - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • NEC Capital Solutions Ltd. (8793):企業の財務・戦略的SWOT分析
    NEC Capital Solutions Ltd. (8793) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Physio-Control Inc:医療機器:M&Aディール及び事業提携情報
    Summary Physio-Control Inc (Physio-Control), a subsidiary of Stryker Corp, is a manufacturer of emergency medical response products. The company offers lifepak monitor and defibrillator, lifepak CR plus AED, lifepak express AED, lifenet system, data review software, chest true cprcoaching device, lu …
  • UGL Ltd:企業の戦略的SWOT分析
    UGL Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Recipharm AB (RECI B):医療機器:M&Aディール及び事業提携情報
    Summary Recipharm AB (Recipharm) is a contract development and manufacturing organization (CDMO) that offers manufacturing, and development and technology services. The organization's manufacturing segment provides contract manufacturing of pharmaceuticals such as semi-solids, and oral liquids, soli …
  • Richard Wolf GmbH:企業の戦略的SWOT分析
    Richard Wolf GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Olin Corporation:企業の戦略・SWOT・財務分析
    Olin Corporation - Strategy, SWOT and Corporate Finance Report Summary Olin Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Monarch Casino & Resort, Inc.:企業の戦略・SWOT・財務情報
    Monarch Casino & Resort, Inc. - Strategy, SWOT and Corporate Finance Report Summary Monarch Casino & Resort, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Motus Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Motus Therapeutics Inc (Motus), formerly Rhythm Pharmaceuticals, Inc. is a subsidiary of Rhythm Holding Company LLC, biotechnology company that provides therapies. The company develops peptide therapeutics for the treatment of metabolic diseases. Its products under clinical development inclu …
  • Idemitsu Kosan Co., Ltd.:企業の戦略・SWOT・財務分析
    Idemitsu Kosan Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Idemitsu Kosan Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Saia Inc (SAIA):企業の財務・戦略的SWOT分析
    Saia Inc (SAIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Recordati SpA (REC):製薬・医療:M&Aディール及び事業提携情報
    Summary Recordati SpA (Recordati), a subsidiary of Fimei SpA is a pharmaceutical company that researches, develops, manufactures and markets pharmaceuticals. The company offers pharmaceuticals for cardiovascular diseases, dermatology, central nervous system disorders, musculo-skeletal disorders and …
  • Ansaldo Energia SpA-エネルギー分野:企業M&A・提携分析
    Summary Ansaldo Energia S.p.A. (Ansaldo Energia), a subsidiary of CDP Equity SpA, is a power generation company and a supplier of power plant equipments and related services. It provides power plant equipments such as gas turbines, steam turbines, turbogenerators, and hydrogenerators used in fossil …
  • Clovis Oncology Inc (CLVS):医療機器:M&Aディール及び事業提携情報
    Summary Clovis Oncology Inc (Clovis) is a biopharmaceutical company that acquires, develops and commercializes new anti-cancer agents. The company's development programs are targeted at specific cancer indications, combining personalized medicine with companion diagnostics. It develops and commercia …
  • Tosoh Bioscience Inc:企業の製品パイプライン分析2018
    Summary Tosoh Bioscience Inc (TBI), a subsidiary of Tosoh Corp, is a medical device company that offers diagnostic systems. The company provides analyzers, assays, immunoassay solutions, reagent technology, HbA1c solutions, ß-thalassemia testing, and HPLC technology. Its immunoassay solutions compri …
  • Vyome Biosciences Pvt Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Vyome Biosciences Pvt Ltd (Vyome) is a research center that develops drugs for antibiotics-resistant acne and other opportunist pathogens. The center’s platforms modify active agents based on genomic information of the disease causing micro organism. Its pro-drug platform develops therapeuti …
  • Vale Canada Ltd:企業の戦略・SWOT・財務情報
    Vale Canada Ltd - Strategy, SWOT and Corporate Finance Report Summary Vale Canada Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆